Stay Informed on Corporate Sustainability

Author: Marubeni

Marubeni Corporation has completed its investment in Phillips Pharma, strengthening its pharmaceutical strategic platform across 26 countries and regions.

Author: Business Inquirer

The Department of Trade and Industry is partnering with AstraZeneca Philippines to establish a Pharma Innovation Hub aimed at driving healthcare innovation and expanding access to affordable medicines.

Author: Irish Independent

Novartis Ireland saw pre-tax profits fall 25 percent to €8.4 million in the last year as revenues declined 10 percent to €242.3 million, reflecting price and volume erosion of mature products.

Author: PT

Eli Lilly will increase the UK list price of Mounjaro (tirzepatide) from £92–£122 to £133–£330 per month starting 1 September.

Author: Irish Independent

Eli Lilly and Johnson & Johnson have highlighted risks to Ireland’s pharmaceutical sector as US trade uncertainties grow. Companies warned that EU regulations, supply chain vulnerabilities, and a need for a skilled workforce could impact Ireland’s position as a life sciences hub.

Author: EPR

WuXi Biologics’ Dundalk facility has received European Medicines Agency approval to begin commercial production of a global client’s innovative biologic.

Author: April Lara

This week reminds us that progress in pharmaceuticals comes in many forms.

Author: April Lara

Navigate Brazil’s ANVISA regulations with SGS expertise for faster approvals, reduced risk and smooth market entry.

Author: April Lara

Entering the Pharma Industry Awards 2025 is about more than recognition—it’s a chance to show how your organisation is shaping the future of healthcare.

Author: STAT

Pfizer’s antibody-drug conjugate Padcev, paired with Keytruda, has shown a survival benefit for patients with invasive bladder cancer who cannot undergo cisplatin chemotherapy.